|
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients Clinical research trials and A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients. A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients clinical trial. Human subjects often obtain the finest healthcare possible for their A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients  A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
For Condition: HIV Infections
Status: No longer recruiting
Sponsor(s): Bristol-Myers Squibb ,
Synopsis: The purpose of this study is to compare the safety and effectiveness of two anti-HIV drug combinations when given to HIV-infected patients who have never been treated with anti-HIV drugs. One drug combination is stavudine (d4T) plus didanosine (ddI) plus Crixivan. The other combination is Retrovir (AZT) plus Epivir (3TC) plus Crixivan.
Details: 100 patients will be randomized to receive Zerit (Stavudine) + Videx (Didanosine) + Crixivan (Indinavir) and 100 patients will be randomized to receive Retrovir (Zidovudine) + Epivir (Lamivudine) + Crixivan (Indinavir). Patients will be treated for 48 weeks.
Eligibility:
Study Type: Interventional, Treatment, Parallel Assignment, Safety Study
Minimum Age/Maximum Age: 16 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - Documented HIV infection. - CD4 cell count of 200 - 700 cells/mm3. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: AIDS defining condition within 1 month of study entry. Prior Medication: Excluded: Patients with any history of antiretroviral therapy treatment.
Total Enrollment: 200
Location and Contact Information:
The Nalle Clinic / Clinical Research Dept
Charlotte, North Carolina, 28207
United States
Univ of Nebraska
Omaha, Nebraska, 68195
United States
Univ of North Carolina / Infectious Disease Division
Chapel Hill, North Carolina, 27599
United States
Northwestern Univ
Chicago, Illinois, 60611
United States
Anderson Clinical Research
Washington D.C., District of Columbia, 20037
United States
Southwest Infectious Disease Association / PA
Dallas, Texas, 75225
United States
Univ of Texas Southwestern Med Ctr of Dallas
Dallas, Texas, 75235
United States
Harbor UCLA Med Ctr / Division of Immunology / N-24
Torrance, California, 90509
United States
East Bay AIDS Clinic
Berkeley, California, 94705
United States
Univ of Pennsylvania / Infectious Diseases Division
Philadelphia, Pennsylvania, 19104
United States
Chicago Ctr for Clinical Research
Chicago, Illinois, 60610
United States
George Washington Med Ctr / Clinical Trials Unit
Washington D.C., District of Columbia, 20037
United States
Hosp Regional de Ponce - Area Vieja
Ponce, , 00731
Puerto Rico
Additional Information:
Study ID Numbers: 260B; BMS 002
Study Start Date:
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002168
Other Hiv Infections Studies:
1. Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
2. A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs
3. A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
4. Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
5. Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients
Related Studies:
Other HIV Infections Clinical Trials
Other Illinois Clinical Trials
Other Chicago Clinical Trials
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
|
|
|
|
|
|
|
|
